The MHRA is currently investigating an incident where several medicines appear to have left the legal supply chain and have then been re-introduced via Kingsley Specials Ltd WDA(H) 49276, who purchased from a company that do not hold a wholesale dealers authorisation and then sold it on to a number of other wholesalers.
MDR 101-08/20Company Name
WDA(H) 49276 Kingsley Specials Ltd
The MHRA is currently investigating an incident where several medicines appear to have left the legal supply chain and have then been re-introduced via Kingsley Specials Ltd WDA(H) 49276, who purchased from a company that does not hold a wholesale dealers authorisation and then sold it on to a number of other wholesalers.
The products do appear to be genuine with legitimate batch numbers and safety features. These products are thought to have left the legitimate supply chain and been reintroduced between March and August 2020. This means that the correct transport and storage conditions cannot be guaranteed and, while unlikely, could impact their effectiveness.
Only the products mentioned in appendix 2 are within the scope of this alert. Please follow the advice below if you have received any of the products listed in appendix 2 from:
- WDA(H) 42332 Smartway Pharmaceuticals Limited
- WDA(H) 20912 Drugsrus Limited
- WDA(H) 48028 Optimal Pharma Limited
Please note, the above wholesalers did not procure the products listed directly from Kingsley Specials Ltd. These products were sold onwards by intermediate companies and the companies listed above are not implicated of any wrongdoing and are co-operating with the MHRA to resolve the matter.Advice for healthcare professionals
Please check your stocks of all the listed products for the relevant batches supplied from the above companies. If any relevant packs are identified, please quarantine and notify the Defective Medicines Report Centre (DMRC)/MHRA.
The above wholesalers have implemented safety measures by decommissioning the impacted packs, changing the status to STOLEN/INACTIVE in the National Medicines Verification System (NMVS). When scanning the serialised 2D code, the status of packs will report as ‘STOLEN’ and/or ‘INACTIVE.’ These products have been shared with other wholesalers prior to procurement at pharmacy level, th
Country of origin
Country for notification
Source of the alert
MHRA - Medicines & Healthcare products Regulatory Agency, www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
Download the application
Download our application and monitor threats! Scan products and feel safe every day. Check it out today!